US7462605B2
(en)
|
1998-01-23 |
2008-12-09 |
Celmed Oncology (Usa), Inc. |
Phosphoramidate compounds and methods of use
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
EA007867B1
(ru)
|
2000-05-26 |
2007-02-27 |
Айденикс (Кайман) Лимитед |
Композиции для лечения флавивирусных и пестивирусных инфекций и способы их применения
|
US7824851B2
(en)
|
2002-11-15 |
2010-11-02 |
Idenix Pharmaceuticals, Inc. |
2′-branched nucleosides and Flaviviridae mutation
|
EP2345659A1
(en)
|
2003-05-30 |
2011-07-20 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
CN101023094B
(zh)
*
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
EP1809301B1
(en)
*
|
2004-09-14 |
2019-11-06 |
Gilead Pharmasset LLC |
2-fluoro-2-alkyl-substituted d-ribonolactone intermediates
|
EP1827460A4
(en)
|
2004-12-09 |
2012-03-14 |
Univ Minnesota |
NUCLEOSIDE WITH ANTIVIRAL AND ANTI-CANCER EFFECT
|
GB0505781D0
(en)
*
|
2005-03-21 |
2005-04-27 |
Univ Cardiff |
Chemical compounds
|
DE102006037786A1
(de)
|
2006-08-11 |
2008-03-20 |
Resprotect Gmbh |
Nukleoside, diese enthaltendes Arzneimittel und deren Verwendung
|
EP2099461B1
(en)
*
|
2006-11-13 |
2012-03-28 |
Santaris Pharma A/S |
Lna nucleoside phosphoramidates
|
GB0623493D0
(en)
|
2006-11-24 |
2007-01-03 |
Univ Cardiff |
Chemical compounds
|
AU2014233579B2
(en)
*
|
2007-03-30 |
2016-06-23 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidate prodrugs
|
US7964580B2
(en)
*
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
GB0709791D0
(en)
*
|
2007-05-22 |
2007-06-27 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
FR2922551B1
(fr)
*
|
2007-10-17 |
2009-12-25 |
Univ Claude Bernard Lyon |
Prodrogues phosphoesters de la gemcitabine comme agents anticancereux
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
US8716262B2
(en)
|
2008-12-23 |
2014-05-06 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
US8551973B2
(en)
|
2008-12-23 |
2013-10-08 |
Gilead Pharmasset Llc |
Nucleoside analogs
|
SG194404A1
(en)
|
2008-12-23 |
2013-11-29 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
NZ599404A
(en)
|
2009-09-21 |
2014-02-28 |
Gilead Sciences Inc |
Processes and intermediates for the preparation of 1’-substituted carba-nucleoside analogs
|
CN104017020B
(zh)
|
2010-03-31 |
2017-04-12 |
吉利德制药有限责任公司 |
核苷氨基磷酸酯
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
ES2524356T3
(es)
|
2010-07-22 |
2014-12-05 |
Gilead Sciences, Inc. |
Métodos y compuestos para tratar infecciones provocadas por virus Paramyxoviridae
|
KR20130110170A
(ko)
|
2010-09-22 |
2013-10-08 |
앨리오스 바이오파마 인크. |
치환된 뉴클레오타이드 유사체
|
GB201016855D0
(en)
*
|
2010-10-06 |
2010-11-17 |
Nucana Biomed Ltd |
Chemical compounds
|
WO2012075140A1
(en)
|
2010-11-30 |
2012-06-07 |
Pharmasset, Inc. |
Compounds
|
US9156874B2
(en)
|
2011-01-03 |
2015-10-13 |
Nanjing Molecular Research, Inc. |
Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs
|
WO2012094248A1
(en)
|
2011-01-03 |
2012-07-12 |
Nanjing Molecular Research, Inc. |
O-(substituted benzyl) phosphoramidate compounds and therapeutic use
|
PT3031812T
(pt)
*
|
2011-03-01 |
2018-10-18 |
NuCana plc |
Compostos químicos
|
CA2843324A1
(en)
|
2011-03-31 |
2012-11-15 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
EP2755983B1
(en)
|
2011-09-12 |
2017-03-15 |
Idenix Pharmaceuticals LLC. |
Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
|
HUE036588T2
(hu)
|
2011-09-16 |
2018-07-30 |
Gilead Pharmasset Llc |
Eljárások HCV kezelésére
|
EP2768838A1
(en)
|
2011-10-14 |
2014-08-27 |
IDENIX Pharmaceuticals, Inc. |
Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
US8466159B2
(en)
|
2011-10-21 |
2013-06-18 |
Abbvie Inc. |
Methods for treating HCV
|
UY34402A
(es)
|
2011-10-21 |
2013-05-31 |
Abbvie Inc |
Métodos para el tratamiento de hcv
|
CH707030B1
(de)
|
2011-10-21 |
2015-03-13 |
Abbvie Inc |
Kombinationsbehandlung von DAAs zur Verwendung in der Behandlung von HCV
|
US8492386B2
(en)
|
2011-10-21 |
2013-07-23 |
Abbvie Inc. |
Methods for treating HCV
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
PE20141423A1
(es)
|
2011-12-20 |
2014-10-16 |
Hoffmann La Roche |
Derivados nucleosidos con sustitucion 2',4'-difluoro-2'-metilo como inhibidores de la replicacion del arn del vhc
|
HUE033332T2
(en)
|
2011-12-20 |
2017-11-28 |
Riboscience Llc |
4'-Azido-3'-fluoro-substituted nucleoside derivatives as inhibitors of HCV RNA replication
|
US8980865B2
(en)
|
2011-12-22 |
2015-03-17 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
CN104321333A
(zh)
|
2012-03-21 |
2015-01-28 |
沃泰克斯药物股份有限公司 |
硫代氨基磷酸酯核苷酸前药的固体形式
|
NZ630805A
(en)
|
2012-03-22 |
2016-01-29 |
Alios Biopharma Inc |
Pharmaceutical combinations comprising a thionucleotide analog
|
NZ701245A
(en)
|
2012-03-28 |
2015-12-24 |
Fujifilm Corp |
Salt of 1-(2-deoxy-2-fluoro-4-thio-β-d-arabinofuranosyl)cytosine
|
NZ702744A
(en)
|
2012-05-22 |
2016-12-23 |
Idenix Pharmaceuticals Llc |
D-amino acid compounds for liver disease
|
EP2852604B1
(en)
|
2012-05-22 |
2017-04-12 |
Idenix Pharmaceuticals LLC |
3',5'-cyclic phosphoramidate prodrugs for hcv infection
|
US9296778B2
(en)
|
2012-05-22 |
2016-03-29 |
Idenix Pharmaceuticals, Inc. |
3′,5′-cyclic phosphate prodrugs for HCV infection
|
CA2871547C
(en)
|
2012-05-25 |
2021-05-25 |
Janssen R&D Ireland |
Uracyl spirooxetane nucleosides
|
CN104640444B
(zh)
*
|
2012-06-16 |
2016-12-14 |
河南美泰宝生物制药有限公司 |
双肝脏靶向氨基磷酸酯和氨基膦酸酯前药
|
ES2718307T3
(es)
|
2012-08-13 |
2019-07-01 |
Fujifilm Corp |
Intermedio para la síntesis de 1-(2-desoxi-2-fluoro-4-tio-beta-d-arabinofuranosil)citosina, intermedio para la síntesis de tionucleósido y métodos para producir estos intermedios
|
CN107312039B
(zh)
|
2012-08-30 |
2019-06-25 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药的制备方法
|
EP2900682A1
(en)
|
2012-09-27 |
2015-08-05 |
IDENIX Pharmaceuticals, Inc. |
Esters and malonates of sate prodrugs
|
CN104936970A
(zh)
|
2012-10-08 |
2015-09-23 |
埃迪尼克斯医药公司 |
用于hcv感染的2′-氯核苷类似物
|
US10723754B2
(en)
|
2012-10-22 |
2020-07-28 |
Idenix Pharmaceuticals Llc |
2′,4′-bridged nucleosides for HCV infection
|
AU2013346515B2
(en)
*
|
2012-11-16 |
2017-05-25 |
NuCana plc |
Process for preparing nucleoside prodrugs
|
WO2014099941A1
(en)
|
2012-12-19 |
2014-06-26 |
Idenix Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
LT2950786T
(lt)
|
2013-01-31 |
2020-03-10 |
Gilead Pharmasset Llc |
Dviejų antivirusinių junginių preparatų kompozicija
|
US10034893B2
(en)
|
2013-02-01 |
2018-07-31 |
Enanta Pharmaceuticals, Inc. |
5, 6-D2 uridine nucleoside/tide derivatives
|
US9339541B2
(en)
|
2013-03-04 |
2016-05-17 |
Merck Sharp & Dohme Corp. |
Thiophosphate nucleosides for the treatment of HCV
|
US9309275B2
(en)
|
2013-03-04 |
2016-04-12 |
Idenix Pharmaceuticals Llc |
3′-deoxy nucleosides for the treatment of HCV
|
WO2014160484A1
(en)
|
2013-03-13 |
2014-10-02 |
Idenix Pharmaceuticals, Inc. |
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
|
EP2981542B1
(en)
|
2013-04-01 |
2021-09-15 |
Idenix Pharmaceuticals LLC |
2',4'-fluoro nucleosides for the treatment of hcv
|
CN105377868A
(zh)
|
2013-04-12 |
2016-03-02 |
艾其林医药公司 |
用于治疗hcv的高活性核苷衍生物
|
US20180200280A1
(en)
|
2013-05-16 |
2018-07-19 |
Riboscience Llc |
4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
|
KR102241198B1
(ko)
|
2013-05-16 |
2021-04-15 |
리보사이언스 엘엘씨 |
4'-플루오로-2'-메틸 치환된 뉴클레오시드 유도체
|
EA201592185A1
(ru)
|
2013-05-16 |
2016-05-31 |
Рибосайенс Ллк |
4'-азидо, 3'-дезокси-3'-фторзамещенные нуклеозидные производные
|
EP3004130B1
(en)
|
2013-06-05 |
2019-08-07 |
Idenix Pharmaceuticals LLC. |
1',4'-thio nucleosides for the treatment of hcv
|
US20150037282A1
(en)
|
2013-08-01 |
2015-02-05 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
NZ716840A
(en)
|
2013-08-27 |
2017-06-30 |
Gilead Pharmasset Llc |
Combination formulation of two antiviral compounds
|
WO2015056213A1
(en)
*
|
2013-10-17 |
2015-04-23 |
Medivir Ab |
Hcv polymerase inhibitors
|
RU2016125213A
(ru)
*
|
2013-11-27 |
2017-12-29 |
АЙДЕНИКС ФАРМАСЬЮТИКАЛЗ ЭлЭлСи |
Нуклеотиды для лечения рака печени
|
CN106061959B
(zh)
|
2014-02-18 |
2018-11-09 |
富士胶片株式会社 |
四氢噻吩骨架型糖化合物的制造方法及四氢噻吩骨架型糖化合物
|
JP6204223B2
(ja)
|
2014-02-19 |
2017-09-27 |
富士フイルム株式会社 |
チオピラノース化合物等の製造方法
|
CN103804446A
(zh)
*
|
2014-02-27 |
2014-05-21 |
苏州东南药业股份有限公司 |
一种3,5-二苯甲酰基-2-去氧-2-氟-2甲基-D-核糖-γ-内酯的制备方法
|
US10202411B2
(en)
|
2014-04-16 |
2019-02-12 |
Idenix Pharmaceuticals Llc |
3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV
|
PL3119794T3
(pl)
|
2014-06-25 |
2018-04-30 |
NuCana plc |
Preparat zawierający prolek gemcytabiny
|
CN106459129B
(zh)
*
|
2014-06-25 |
2020-03-31 |
努卡那有限公司 |
吉西他滨前药
|
JP6646663B2
(ja)
*
|
2014-07-22 |
2020-02-14 |
ニューカナ バイオメッド リミテッドNucana Biomed Limited |
ゲムシタビン−[フェニル(ベンゾキシ−l−アラニニル)]ホスフェートの製造方法リン酸誘導体を製造する方法
|
CN107074826B
(zh)
|
2014-08-25 |
2020-05-22 |
美迪维尔公司 |
用于治疗癌症的尿苷的二氧戊环类似物
|
US9675632B2
(en)
|
2014-08-26 |
2017-06-13 |
Enanta Pharmaceuticals, Inc. |
Nucleoside and nucleotide derivatives
|
GB201417644D0
(en)
*
|
2014-10-06 |
2014-11-19 |
Nucana Biomed Ltd |
Method of separating phosphate diastereoisomers
|
TWI698444B
(zh)
|
2014-10-29 |
2020-07-11 |
美商基利科學股份有限公司 |
製備核糖苷的方法
|
CA2966033A1
(en)
*
|
2014-10-31 |
2016-05-06 |
Cocrystal Pharma, Inc. |
2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
|
TWI678373B
(zh)
*
|
2014-10-31 |
2019-12-01 |
日商富士軟片股份有限公司 |
硫代核苷衍生物或其鹽及醫藥組合物
|
WO2016073756A1
(en)
|
2014-11-06 |
2016-05-12 |
Enanta Pharmaceuticals, Inc. |
Deuterated nucleoside/tide derivatives
|
EA031727B1
(ru)
|
2014-11-28 |
2019-02-28 |
Нукана Байомед Лимитед |
Новые производные 2'- и/или 5'-аминокислотных эфиров фосфороамидатов 3'-дезоксиаденозина в качестве противораковых соединений
|
US9732110B2
(en)
|
2014-12-05 |
2017-08-15 |
Enanta Pharmaceuticals, Inc. |
Nucleoside and nucleotide derivatives
|
KR20170110591A
(ko)
|
2014-12-15 |
2017-10-11 |
에모리 유니버시티 |
B형 간염 치료용 포스포르아미테이트
|
WO2016134058A1
(en)
|
2015-02-18 |
2016-08-25 |
Abbvie Inc. |
Combinations useful to treat hepatitis c virus
|
EP3265102A4
(en)
|
2015-03-06 |
2018-12-05 |
ATEA Pharmaceuticals, Inc. |
Beta-d-2'-deoxy-2'alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substituted purine nucleotides for hcv treatment
|
CA2975990A1
(en)
*
|
2015-04-03 |
2016-10-06 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Novel compound of 4'-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof
|
EP3197456B2
(en)
*
|
2015-05-14 |
2023-10-11 |
NuCana plc |
Cancer treatments
|
TWI695841B
(zh)
*
|
2015-06-22 |
2020-06-11 |
瑞典商米迪維艾克提伯拉公司 |
治療癌症之前藥
|
JP6743135B2
(ja)
*
|
2015-09-02 |
2020-08-19 |
アッヴィ・インコーポレイテッド |
抗ウィルス性テトラヒドロフラン誘導体
|
CN106543220A
(zh)
*
|
2015-09-16 |
2017-03-29 |
博瑞生物医药(苏州)股份有限公司 |
氨基磷酸酯化合物及其制备方法和晶体
|
ES2918585T3
(es)
|
2015-09-16 |
2022-07-19 |
Gilead Sciences Inc |
Métodos para el tratamiento de infecciones por el virus Arenaviridae
|
CN106539810B
(zh)
*
|
2015-09-16 |
2021-03-09 |
济南高合医疗科技有限公司 |
一种富集了nuc-1031单一异构体的组合物及其制备方法和用途
|
CN106543252A
(zh)
*
|
2015-09-16 |
2017-03-29 |
博瑞生物医药(苏州)股份有限公司 |
核苷氨基磷酸酯类前药的制备方法及其中间体
|
US10660912B2
(en)
*
|
2015-10-05 |
2020-05-26 |
NuCana plc |
Combination therapy for cancer
|
SI3386998T1
(sl)
*
|
2015-12-11 |
2022-02-28 |
NuCana plc |
Diastereoselektivna sinteza fosfatnih derivatov in predzdravila gemcitabina NUC-1031
|
US20190381084A1
(en)
|
2015-12-23 |
2019-12-19 |
Nucana Biomed Limited |
Combination therapy
|
GB201522771D0
(en)
|
2015-12-23 |
2016-02-03 |
Nucana Biomed Ltd |
Crystalline form of a phosphate derivative
|
AU2016375861B2
(en)
*
|
2015-12-23 |
2021-12-23 |
NuCana plc |
Combination therapy
|
EP3448392A4
(en)
|
2016-04-28 |
2020-01-15 |
Emory University |
ALCYNE-CONTAINING NUCLEOTIDES AND NUCLEOSIDES THERAPEUTIC COMPOSITIONS AND USES THEREOF
|
GB201609600D0
(en)
*
|
2016-06-01 |
2016-07-13 |
Nucuna Biomed Ltd |
Cancer treatments
|
EP3474863A4
(en)
|
2016-06-24 |
2020-03-25 |
Emory University |
PHOSPHORAMIDATE FOR TREATING THE HEPATITIS C VIRUS
|
LU100724B1
(en)
|
2016-07-14 |
2018-07-31 |
Atea Pharmaceuticals Inc |
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
|
CA3035334C
(en)
|
2016-08-31 |
2022-05-10 |
Fujifilm Corporation |
Combination of paclitaxel and 1-(2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranosyl)-cytosine as anti-tumor agent
|
MY197236A
(en)
|
2016-09-07 |
2023-06-07 |
Atea Pharmaceuticals Inc |
2'-substituted-n6-substituted purine nucleotides for rna virus treatment
|
US10682368B2
(en)
|
2017-03-14 |
2020-06-16 |
Gilead Sciences, Inc. |
Methods of treating feline coronavirus infections
|
CA3178212A1
(en)
|
2017-05-01 |
2018-11-08 |
Gilead Sciences, Inc. |
Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
|
GB201709471D0
(en)
|
2017-06-14 |
2017-07-26 |
Nucana Biomed Ltd |
Diastereoselective synthesis of hosphate derivatives
|
CN109134568B
(zh)
*
|
2017-06-15 |
2022-11-22 |
北京美倍他药物研究有限公司 |
核苷磷酸酯/酰胺衍生物及其医药用途
|
US10675296B2
(en)
|
2017-07-11 |
2020-06-09 |
Gilead Sciences, Inc. |
Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
|
US11266674B2
(en)
|
2017-09-01 |
2022-03-08 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Pharmaceutical composition for tumor treatment or prevention, method, and use thereof
|
GB201715011D0
(en)
|
2017-09-18 |
2017-11-01 |
Nucana Biomed Ltd |
Floxuridine synthesis
|
WO2019060740A1
(en)
|
2017-09-21 |
2019-03-28 |
Riboscience Llc |
4'-FLUORO-2'-METHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION
|
GB201720279D0
(en)
|
2017-12-05 |
2018-01-17 |
Nucana Biomed Ltd |
Anticancer compounds
|
WO2019146130A1
(ja)
|
2018-01-29 |
2019-08-01 |
富士フイルム株式会社 |
胆道がん用抗腫瘍剤および胆道がんの処置方法
|
KR20200118828A
(ko)
*
|
2018-02-02 |
2020-10-16 |
마베릭스 온콜로지, 잉크. |
신규한 젬시타빈 유도체의 소분자 약물 컨쥬게이트
|
CN112135634A
(zh)
|
2018-02-02 |
2020-12-25 |
马福瑞克斯肿瘤学股份有限公司 |
单磷酸吉西他滨的小分子药物偶联物
|
JP6810763B2
(ja)
*
|
2019-03-06 |
2021-01-06 |
ニューカナ パブリック リミテッド カンパニー |
がん治療
|
GB201904544D0
(en)
|
2019-04-01 |
2019-05-15 |
NuCana plc |
Anticancer compounds
|
KR20220132608A
(ko)
|
2020-01-27 |
2022-09-30 |
길리애드 사이언시즈, 인코포레이티드 |
SARS CoV-2 감염증을 치료하기 위한 방법
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
WO2021173713A1
(en)
|
2020-02-27 |
2021-09-02 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against covid-19
|
JP2023516087A
(ja)
|
2020-03-12 |
2023-04-17 |
ギリアード サイエンシーズ, インコーポレイテッド |
1’-シアノヌクレオシドを調製する方法
|
CA3172483A1
(en)
|
2020-04-06 |
2021-10-14 |
Scott Ellis |
Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
|
AU2021281351A1
(en)
|
2020-05-29 |
2023-01-19 |
Gilead Sciences, Inc. |
Remdesivir treatment methods
|
PE20230618A1
(es)
|
2020-06-24 |
2023-04-14 |
Gilead Sciences Inc |
Analogos de nucleosido de 1'-ciano y usos de los mismos
|
WO2022031150A1
(ko)
*
|
2020-08-07 |
2022-02-10 |
주식회사 피노바이오 |
데옥시사이티딘계 항암제 및 실릴 에테르 함유 링커를 포함하는 접합체 및 이의 용도
|
IL300453A
(en)
|
2020-08-27 |
2023-04-01 |
Gilead Sciences Inc |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
|
TW202400185A
(zh)
|
2022-03-02 |
2024-01-01 |
美商基利科學股份有限公司 |
用於治療病毒感染的化合物及方法
|